News

Study tracks teens on isotretinoin, finding stable cognition but modest rises in depression and anxiety symptoms, reinforcing the need for ongoing mental health monitoring.

FDA granted QRX003 RPD designation for PSS, adding to its Netherton syndrome designation as Quoin prepares for a phase 2 study.

Real-world cohort research links psoriasis biologics to notably fewer heart attacks and strokes over 10 years, with benefits across drug classes and races.

Put your dermatology expertise to the test with Dermatology Times’ interactive quiz series.

Are "clean" skin care routines legitimate, or are they just a myth? Read more about the latest social media trend and learn how to counsel your patients in the clinic.

Clinicians can bridge the gap between online trends and evidence-based outcomes by leveraging patient curiosity, emphasizing ingredient transparency, and delivering personalized in-office care.

Joshua Arbesman, MD, explains how tailored sun-safety advice balances melanoma risk, aging goals, and quality of life in all types of patients.

AbbVie completed its $10.9 billion Apogee acquisition, adding IL-13 antibody zumilokibart and other inflammatory disease assets.

Joshua Arbesman, MD, explains how to promote smarter sun habits, educate on melanoma-risk timelines, ease guilt, and answer sunscreen fears fueled by social media.

New CSU treatments like dupilumab, omalizumab and fast-acting remibrutinib, plus biomarker-driven therapies on the horizon, move beyond antihistamines.

This review of the latest dermatological studies includes insights on adalimumab durability in HS, medicolegal issues in hair transplantation, yellow light and vitamin C for melasma, and more.

CSU links to autoimmune disease and mental health burden; learn from Nicholas Brownstone, MD, on key screening tips, symptom clues, and how it differs from inducible hives.

ACP outlines ethical AI in medicine: protect patient trust, fight bias, avoid deskilling, and disclose AI use as dermatology adopts new tools.

Dermatology Times is looking back on the top stories in dermatology from the month of August.

Explore the top headlines of the month, including insights on the latest clinical trials, therapeutic updates, and more.

Explore the top dermatology conferences and meetings happening this month and let us know which ones you'll be attending!

Physicians' Education Resource and Dermatology Times debut a dedicated NP/PA education platform and a new congress series, opening with DermNexus this November in Scottsdale, Arizona.

In this first episode, Joshua Zeichner, MD, shares how to spot early male pattern thinning, why it affects confidence, and which proven treatments beat social media hype.

A twice-rejected melanoma immunotherapy finally won accelerated approval, acne's decades-long innovation drought moved a step closer to ending, and 2 rare, sun-triggered skin diseases picked up a deep-pocketed new sponsor.

Week 52 data show ixekizumab plus tirzepatide sustained or improved disease activity and metabolic outcomes in psoriasis and psoriatic arthritis.

Lisa Swanson, MD, joins Don't Be Rash host Andrew C. Krakowski, MD, for Psoriasis Awareness Month to discuss how pediatric psoriasis is often misdiagnosed and when it signals a heightened risk of psoriatic arthritis in kids.

Put your dermatology expertise to the test with Dermatology Times’ interactive quiz series.

Shawn Demehri, MD, PhD, discussed immunomodulatory and antigen-directed immunotherapy approaches for skin cancer prevention in a recent Dermatology Times interview.

Jennifer Soung, MD, discusses whole patient care for psoriasis and alopecia areata and why setting realistic expectations matters for hair regrowth.

Shawn Demehri, MD, PhD, discusses a calcipotriene/5-FU combination immunotherapy for field cancerization and its potential in organ transplant recipients.

Does "flooding" with 5 to 7 products every night really hydrate the skin or is it just a myth? Read more about the latest social media trend and learn how to counsel your patients in the clinic.

In this episode, Renata Block, DMSc, MMS, PA-C, welcomed Obehi Oriaifo, DNP, FNP-BC, DCNP, founder of DermaNP Solutions, to discuss expanding teledermatology access for rural and underserved patients.

This month’s podcasts highlight the latest clinical insights, emerging therapies, and evolving conversations shaping dermatology practice.

New biopsies reveal hidden scalp inflammation in dissecting cellulitis, even in normal-looking skin, hinting at a field effect behind stubborn recurrences.

Quoin reported positive interim phase 2/3 results for QRX003, which met the primary endpoint in patients with Netherton syndrome.